Skip to main content
Premium Trial:

Request an Annual Quote

ATCC Inks Sales Pact with Life Technologies for GFP Technology

NEW YORK (GenomeWeb News) – ATCC today announced a deal with Life Technologies to sell green fluorescent proteins to distributors, non-commercial customers, and government customers in the research field.

Under the terms of the deal, which excludes the food and environmental safety testing sectors, ATCC will be able to use GFP technology to develop biological materials for the covered research fields.

Life Tech serves as the exclusive for-profit entity to ATCC for GFP-based materials, though the non-profit biological materials resource and standards organization can also obtain GFP materials from third party, non-profit, or government researchers, it said.

ATCC must distribute licensed products with a Limited Label License Agreement accompanying the distribution. Licensed products may be sold to for-profit customers only if they have a license with Life Technologies or GE Healthcare, and ATCC does not have any sublicensing rights.

ATCC will develop and manufacture products at its Manassas, Va., and Gaithersburg, Md., facilities.

"With this license, ATCC can accept a wide variety of GFP-based materials into our collections and we can make these materials available to meet the evolving needs of researchers," Brian A. Pollok, president of ATCC, said in a statement. "ATCC also plans to use GFP technology, together with our unique bioassets, to generate novel products intended to advance understanding in cell biology, infectious disease, and other key research fields."

Financial and other terms were not disclosed.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.